Skip to main content
. 2022 Aug 4;17:3483–3495. doi: 10.2147/IJN.S372851

Scheme 1.

Scheme 1

Isolated exosomes were released from BM-MSC cells and loaded with doxorubicin to form a complex (Exo-Dox). We then evaluated the targeted antitumor effect of Exo-Dox both in vitro (A) and in vivo (B).